Form 8-K - Current report:
SEC Accession No. 0001144204-15-001721
Filing Date
2015-01-12
Accepted
2015-01-12 09:00:22
Documents
42
Period of Report
2015-01-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v398491_8k.htm 8-K 15827
2 EXHIBIT 99.1 v398491_ex99-1.htm EX-99.1 26257
3 EXHIBIT 99.2 v398491_ex99-2.htm EX-99.2 53188
4 GRAPHIC tlogo.jpg GRAPHIC 10379
5 GRAPHIC image_038.jpg GRAPHIC 3892
6 GRAPHIC image_001.jpg GRAPHIC 148540
7 GRAPHIC image_002.jpg GRAPHIC 500990
8 GRAPHIC image_003.jpg GRAPHIC 189444
9 GRAPHIC image_004.jpg GRAPHIC 125986
10 GRAPHIC image_005.jpg GRAPHIC 390021
11 GRAPHIC image_006.jpg GRAPHIC 105615
12 GRAPHIC image_007.jpg GRAPHIC 155977
13 GRAPHIC image_008.jpg GRAPHIC 162638
14 GRAPHIC image_009.jpg GRAPHIC 145949
15 GRAPHIC image_010.jpg GRAPHIC 135358
16 GRAPHIC image_011.jpg GRAPHIC 147550
17 GRAPHIC image_012.jpg GRAPHIC 178470
18 GRAPHIC image_013.jpg GRAPHIC 136834
19 GRAPHIC image_014.jpg GRAPHIC 173820
20 GRAPHIC image_015.jpg GRAPHIC 180694
21 GRAPHIC image_016.jpg GRAPHIC 163770
22 GRAPHIC image_017.jpg GRAPHIC 177459
23 GRAPHIC image_018.jpg GRAPHIC 186860
24 GRAPHIC image_019.jpg GRAPHIC 107965
25 GRAPHIC image_020.jpg GRAPHIC 131990
26 GRAPHIC image_021.jpg GRAPHIC 156572
27 GRAPHIC image_022.jpg GRAPHIC 153273
28 GRAPHIC image_023.jpg GRAPHIC 218476
29 GRAPHIC image_024.jpg GRAPHIC 237109
30 GRAPHIC image_025.jpg GRAPHIC 215708
31 GRAPHIC image_026.jpg GRAPHIC 227612
32 GRAPHIC image_027.jpg GRAPHIC 145982
33 GRAPHIC image_028.jpg GRAPHIC 194975
34 GRAPHIC image_029.jpg GRAPHIC 165273
35 GRAPHIC image_030.jpg GRAPHIC 318545
36 GRAPHIC image_031.jpg GRAPHIC 157820
37 GRAPHIC image_032.jpg GRAPHIC 249639
38 GRAPHIC image_033.jpg GRAPHIC 157436
39 GRAPHIC image_034.jpg GRAPHIC 208512
40 GRAPHIC image_035.jpg GRAPHIC 196973
41 GRAPHIC image_036.jpg GRAPHIC 161006
42 GRAPHIC image_037.jpg GRAPHIC 189607
  Complete submission text file 0001144204-15-001721.txt   9766719
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 15520742
SIC: 2834 Pharmaceutical Preparations